| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.088 | 0.1 |